Cytokine-induced killer cells: A novel treatment for allergic airway inflammation. [PDF]
PLoS ONE, 2017 The effectiveness of cytokine-induced killer (CIK) cells for treatment of cancers has long been appreciated. Here, we report for the first time that CIK cells can be applied to treat allergic airway inflammation.
Panwadee Pluangnooch +3 more
doaj +5 more sources
Cytokine-Induced Killer Cells As Pharmacological Tools for Cancer Immunotherapy [PDF]
Frontiers in Immunology, 2017 Cytokine-induced killer (CIK) cells are a heterogeneous population of effector CD3+CD56+ natural killer T cells, which can be easily expanded in vitro from peripheral blood mononuclear cells.
Xingchun Gao +11 more
doaj +3 more sources
Cytokine Induced Killer Cells as Promising Immunotherapy for Solid Tumors [PDF]
Journal of Cancer, 2011 Cytokine-induced killer (CIK) cells are a heterogeneous subset of ex-vivo expanded T lymphocytes which present a mixed T-NK phenotype and are endowed with a MHC-unrestricted antitumor activity. The main functional properties of CIK cells may address some
Dario Sangiolo
doaj +4 more sources
Effect of chaetocin on renal cell carcinoma cells and cytokine-induced killer cells [PDF]
GMS German Medical Science, 2016 We examined the cytotoxic effects of chaetocin on clear cell renal cell carcinoma (ccRCC) cells and the possibility to combine the effects of chaetocin with the effects of cytokine-induced killer cells (CIK) assayed by MTT assay and FACS analysis ...
Rombo, Roman +2 more
doaj +3 more sources
Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer: A meta-analysis. [PDF]
Medicine (Baltimore), 2021 Abstract Objectives: This meta-analysis was designed to systematically evaluate whether autologous cytokine-induced killer cells (CIK) or dendritic cells and cytokine-induced killer cells (DC-CIK) immunotherapy combined with chemotherapy can improve the therapeutic effect and safety of chemotherapy in esophageal ...
Yuan X +11 more
europepmc +5 more sources
CAR-CIK vs. CAR-T: benchmarking novel cytokine-induced killer cells as solid tumor immunotherapy in ErbB2+ rhabdomyosarcoma. [PDF]
Front ImmunolMoser LM +16 more
europepmc +2 more sources
Cytokine-induced killer cell/dendritic cell combined with cytokine-induced killer cell immunotherapy for treating advanced gastrointestinal cancer [PDF]
BMC Cancer, 2020 AbstractBackgroundThis study aimed to investigate the efficacy and safety of cytokine-induced killer (CIK)/dendritic cell combined with CIK (DC–CIK) cell therapy in advanced gastrointestinal cancer (GIC).MethodsThe PubMed, Cochrane library, and Embase were searched to conduct a meta-analysis of clinical controlled trials to evaluate the efficacy and ...
Hansong Du, Jia Yang, Ying Zhang
openaire +3 more sources
Translational Oncology, 2022 Dendritic cells (DCs) are the most potent antigen-presenting cells, and have thus been used in clinical cancer vaccines. However, the effects of DC vaccines are still limited, leading researchers to explore novel ways to make them effective.
Tan-Huy Chu +10 more
doaj +1 more source
Cytokine-induced killer cells promote antitumor immunity [PDF]
Journal of Translational Medicine, 2013 The number of immune cells, especially dendritic cells and cytotoxic tumor infiltrating lymphocytes (TIL), particularly Th1 cells, CD8 T cells, and NK cells is associated with increased survival of cancer patients. Such antitumor cellular immune responses can be greatly enhanced by adoptive transfer of activated type 1 lymphocytes.
Jiang, J, Wu, C, Lu, B
openaire +2 more sources
Adoptive Cell Therapy of Melanoma with Cytokine-induced Killer Cells [PDF]
Immune Network, 2015 Melanoma is the most aggressive skin cancer and its incidence is gradually increasing worldwide. Patients with metastatic melanoma have a very poor prognosis (estimated 5-year survival rate of
Kim, Ji Sung +6 more
openaire +2 more sources